When Su Wang was in medical school, she donated blood. That’s when she learned she was infected with hepatitis B, a virus that attacks the liver and can lead to cancer and death decades later. “I was 18, healthy, in college,” she said. “And suddenly I had a chronic illness I didn’t even know about.”…
That is the question asked in a recent Health Affairs Forefront article by Peter Neumann, Josh Cohen, Sean Sullivan and Feng Xie. They compare the CMS negotiated prices for Initial Price Applicability Year (IPAY) 2027 against value-based prices (using QALYs) from the Tufts Cost-Effectiveness Analysis (CEA) Registry. The authors found that cost-effectiveness estimates varied among…
Health systems should take the lead in fixing the broken prior authorization process, said Jeff Balser, CEO of Vanderbilt University Medical Center, during a recent conference. He highlighted AI, better workflows and centralized support as ways to reduce delays. The post Vanderbilt CEO: Health Systems Can Fix Prior Auth Without Waiting for Payers appeared first…
[Sponsored] Pharmacy benefit managers are under scrutiny for their business practices that are often blamed for contributing to the rising costs of prescription drugs in America. But one PBM is paving another way that alters the traditional operating model. The post MedCity Pivot Podcast: A Flexible Approach to Pharmacy Benefits Management appeared first on MedCity…
By STEVEN ZECOLA Recursion Pharmaceuticals announced results today for one its AI-discovered treatments. I was pleased to see the large, sustained reduction in polyps attributable to its treatment for Familial Adenomatous Polyposis. Recursions’ oral medication will be viewed by the traditional scientific and regulatory community as “promising”. On the other hand, I was disappointed not…
The Host Julie Rovner KFF Health News @jrovner @julierovner.bsky.social Read Julie’s stories. Julie Rovner is chief Washington correspondent and host of KFF Health News’ weekly health policy news podcast, “What the Health?” A noted expert on health policy issues, Julie is the author of the critically praised reference book “Health Care Politics and Policy A…
The high dose of Eli Lilly’s retatrutide led to an average 28.7% loss in body weight measured at 68 weeks. These Phase 3 results are the first from the experimental obesity drug’s broad clinical trial program, which is on track to yield seven data readouts in the coming year. The post Eli Lilly Drug for…
We are building a more connected system that bridges acute and post-acute settings by uniting insights across the continuum. The insights empower clinicians with the information they need at the moment they need it, resulting in faster, safer, and more human-centered care. The post How AI Is Reshaping Emergency Departments appeared first on MedCity News.
As economic anxiety rises, KFF’s Health Tracking Poll finds that younger adult, LGBT adults, Hispanic adults, and adults with modest incomes are among groups most likely to report difficulty earning a living and affording health care. Large shares of those who are uninsured or purchase their own insurance also report challenges earning a living and…
A future where ambient technology is integrated across all hospital spaces — patient rooms, ORs, even waiting areas — will revolutionize decision-making to improve care. The post Improving Care Delivery With Ambient Technology appeared first on MedCity News.